# PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

> **NCT06299410** · PHASE1 · RECRUITING · sponsor: **Intra-Cellular Therapies, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ITI-1284 10 mg
- **DRUG:** ITI-1284 20 mg

## Key facts

- **NCT ID:** NCT06299410
- **Lead sponsor:** Intra-Cellular Therapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-11
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06299410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06299410, "PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06299410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*